A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway

[1]  J. Rabinowitz,et al.  T Cell Activation Depends on Extracellular Alanine. , 2019, Cell reports.

[2]  D. Pagliarini,et al.  Two-stage metabolic remodelling in macrophages in response to lipopolysaccharide and interferon-γ stimulation , 2019, Nature Metabolism.

[3]  J. Rabinowitz,et al.  NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism , 2019, Nature Metabolism.

[4]  J. Rabinowitz,et al.  NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism , 2019, Nature Metabolism.

[5]  Y. Murakumo,et al.  Prognostic significance of G6PD expression and localization in lung adenocarcinoma. , 2019, Biochimica et biophysica acta. Proteins and proteomics.

[6]  M. Caraglia,et al.  A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo , 2018, Cell Death & Disease.

[7]  J. Rabinowitz,et al.  Extraction and Quantitation of Nicotinamide Adenine Dinucleotide Redox Cofactors. , 2018, Antioxidants & redox signaling.

[8]  J. Rabinowitz,et al.  Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma , 2017, Proceedings of the National Academy of Sciences.

[9]  J. Rabinowitz,et al.  Chemical Basis for Deuterium Labeling of Fat and NADPH. , 2017, Journal of the American Chemical Society.

[10]  J. Mecsas,et al.  Neutrophils to the ROScue: Mechanisms of NADPH Oxidase Activation and Bacterial Resistance , 2017, Front. Cell. Infect. Microbiol..

[11]  Joshua D. Rabinowitz,et al.  Metabolite Spectral Accuracy on Orbitraps. , 2017, Analytical chemistry.

[12]  A. Perra,et al.  Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma , 2017, Front. Oncol..

[13]  T. Mak,et al.  Glutathione Primes T Cell Metabolism for Inflammation , 2017, Immunity.

[14]  K. C. Huang,et al.  Coupling between Protein Stability and Catalytic Activity Determines Pathogenicity of G6PD Variants. , 2017, Cell reports.

[15]  Yuechun Zhu,et al.  Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma , 2017, Journal of Cancer.

[16]  M. Mann,et al.  L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity , 2016, Cell.

[17]  Michal Sheffer,et al.  Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation. , 2016, Cell metabolism.

[18]  F. Hansen,et al.  HDAC5 controls the functions of Foxp3+ T‐regulatory and CD8+ T cells , 2016, International journal of cancer.

[19]  H. Tse,et al.  NADPH Oxidase–Derived Superoxide Provides a Third Signal for CD4 T Cell Effector Responses , 2016, The Journal of Immunology.

[20]  D. Sabatini,et al.  A PHGDH inhibitor reveals coordination of serine synthesis and 1-carbon unit fate , 2016, Nature chemical biology.

[21]  M. Serrano,et al.  G6PD protects from oxidative damage and improves healthspan in mice , 2016, Nature Communications.

[22]  J. Blenis,et al.  Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers , 2016, Proceedings of the National Academy of Sciences.

[23]  Minghui Zhang,et al.  Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma , 2015, World Journal of Surgical Oncology.

[24]  J. Locasale,et al.  Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses , 2015, Cell.

[25]  M. Buck,et al.  T cell metabolism drives immunity , 2015, The Journal of experimental medicine.

[26]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[27]  A. Cordeiro,et al.  Discovery of New Uncompetitive Inhibitors of Glucose-6-Phosphate Dehydrogenase , 2014, Journal of biomolecular screening.

[28]  J. Rathmell,et al.  The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. , 2014, Cell metabolism.

[29]  T. Shlomi,et al.  Quantitative flux analysis reveals folate-dependent NADPH production , 2014, Nature.

[30]  P. Nordlund,et al.  Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay , 2013, Science.

[31]  B. Faubert,et al.  Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis , 2013, Cell.

[32]  S. Rahlfs,et al.  Identification and Characterization of Novel Human Glucose-6-Phosphate Dehydrogenase Inhibitors , 2013, Journal of biomolecular screening.

[33]  J. Licht,et al.  Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. , 2013, Immunity.

[34]  R. Stanton.  Glucose‐6‐phosphate dehydrogenase, NADPH, and cell survival , 2012, IUBMB life.

[35]  A. Jordan,et al.  Novel steroid inhibitors of glucose 6-phosphate dehydrogenase. , 2012, Journal of medicinal chemistry.

[36]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[37]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[38]  Daniel Amador-Noguez,et al.  Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer. , 2010, Analytical chemistry.

[39]  L. Montaño,et al.  Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV‐positive and HPV‐negative cervical cancer cells through an androgen‐ and estrogen‐receptor independent mechanism , 2009, The FEBS journal.

[40]  Hanna Y. Irie,et al.  Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment , 2009, Nature.

[41]  M. Cappellini,et al.  Glucose-6-phosphate dehydrogenase deficiency , 2008, The Lancet.

[42]  D. Voet,et al.  Comprar Fundamentals of Biochemistry: Life at the Molecular Level, Take Note! | Donald Voet | 9780470228432 | Wiley , 2008 .

[43]  H. Ho,et al.  Dehydroepiandrosterone induces growth arrest of hepatoma cells via alteration of mitochondrial gene expression and function. , 2008, International journal of oncology.

[44]  T. Gajewski,et al.  Glucose Availability Regulates IFN-γ Production and p70S6 Kinase Activation in CD8+ Effector T Cells1 , 2005, The Journal of Immunology.

[45]  P. Pandolfi,et al.  Maternally transmitted severe glucose 6‐phosphate dehydrogenase deficiency is an embryonic lethal , 2002, The EMBO journal.

[46]  A. Pizzini,et al.  Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells. , 1997, British Journal of Cancer.

[47]  K. Tabbara,et al.  Effect of glucose-6-phosphate dehydrogenase deficiency on neutrophil function. , 1997, Acta haematologica.

[48]  A. Goldfarb,et al.  Vitamin E attenuates myocardial oxidative stress induced by DHEA in rested and exercised rats. , 1996, Journal of applied physiology.

[49]  G. Gordon,et al.  On the mechanism of interaction of steroids with human glucose 6-phosphate dehydrogenase. , 1995, Archives of biochemistry and biophysics.

[50]  M. L. Lewbart,et al.  Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16 alpha-fluoro-5-androsten-17-one and its reversal by deoxyribonucleosides. , 1991, Carcinogenesis.

[51]  G. Battistuzzi,et al.  Glucose-6-phosphate dehydrogenase of leukocyte subpopulations in normal and enzyme deficient individuals. , 1985, Haematologica.

[52]  J. Vives Corrons,et al.  Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona). , 1982, Blood.

[53]  A. De Flora,et al.  Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[54]  H. Wood,et al.  The use of C14O2 yields from glucose-1- and -6-C14 for the evaluation of the pathways of glucose metabolism. , 1963, The Journal of biological chemistry.

[55]  P. Marks,et al.  INHIBITION OF MAMMALIAN GLUCOSE-6-PHOSPHATE DEHYDROGENASE BY STEROIDS. , 1960, Proceedings of the National Academy of Sciences of the United States of America.

[56]  P. Marks,et al.  EFFECT OF AGE ON THE ENZYME ACTIVITY IN ERYTHROCYTES. , 1958, Proceedings of the National Academy of Sciences of the United States of America.